BRCA1 gene promoter methylation status in high-grade serous ovarian cancer patients--a study of the tumour Bank ovarian cancer (TOC) and ovarian cancer diagnosis consortium (OVCAD).
about
Homologous Recombination Deficiency: Exploiting the Fundamental Vulnerability of Ovarian CancerDNA methylation changes in epithelial ovarian cancer histotypes.Molecular Classification of Triple-Negative Breast CancerGermline mutations of BRCA1 gene exon 11 are not associated with platinum response neither with survival advantage in patients with primary ovarian cancer: understanding the clinical importance of one of the biggest human exons. A study of the TumorThe BRCA1/2-directed miRNA signature predicts a good prognosis in ovarian cancer patients with wild-type BRCA1/2.Isolation and characterization of side population cells from the human ovarian cancer cell line SK-OV-3Pyrosequencing quantified methylation level of BRCA1 promoter as prognostic factor for survival in breast cancer patientEpigenetics of breast cancer: Modifying role of environmental and bioactive food compounds.Targeting deficient DNA damage repair in gastric cancer.Emergence of the Noncoding Cancer Genome: A Target of Genetic and Epigenetic Alterations.Association of Distinct Mutational Signatures With Correlates of Increased Immune Activity in Pancreatic Ductal Adenocarcinoma.Performance of multiplicom's BRCA MASTR Dx kit on the detection of BRCA1 and BRCA2 mutations in fresh frozen ovarian and breast tumor samplesLoss of BRCA1 promotor hypermethylation in recurrent high-grade ovarian cancer.Epigenetic Reprogramming Strategies to Reverse Global Loss of 5-Hydroxymethylcytosine, a Prognostic Factor for Poor Survival in High-grade Serous Ovarian Cancer.Bi-allelic alterations in DNA repair genes underpin homologous recombination DNA repair defects in breast cancer.HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures.Droplet-based digital PCR and next generation sequencing for monitoring circulating tumor DNA: a cancer diagnostic perspective.STAT3/PIAS3 levels serve as "early signature" genes in the development of high-grade serous carcinoma from the fallopian tube.Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma
P2860
Q26783551-E2581607-AEB4-4717-BADE-918B65AA5BBAQ27690722-EE95F6D7-7C5D-46FA-99B3-E9BE2D9195DCQ28076661-4D4EF994-AC04-421D-A81F-01A754FB6878Q33458308-41075519-E860-4E97-93D2-3BF12738B548Q34455481-21A1BE3F-4551-4355-BC76-709718916D12Q36334147-F05EB12B-E2A5-4323-8355-04B5BE665733Q37317308-8539F572-7D9E-4345-BDCE-DF3FC8E981EFQ38825290-8E767BCE-20D4-456B-A7E6-79DEE4CFA63BQ38834760-F6DF3629-C03D-4308-A8FE-904D9862C1C3Q38997020-A719B0D4-7EED-496B-8B70-463B31E433BEQ39262474-A3E0B14A-8D7B-4CE9-B564-C1905FC65677Q42121714-4C7026A3-D455-4669-AD41-46C447B1F9B5Q45814103-1F4452E9-C92E-4579-8761-19B854B61F71Q47771135-D29D6306-7395-4CE0-85AB-322D3DE2BE8FQ48118236-3DED8F68-9863-48E3-8EFB-91993E9E07D4Q48134701-11072D2A-C7CA-46F3-A39D-DBD2FBDA6970Q48521971-0AA3C8F4-2398-45B3-8D01-D0A5E42853FAQ50020012-BB3BF1E5-EFDB-4564-B7ED-D176ACB48A11Q59126243-12984B4C-72B3-494F-B5DF-117637897772
P2860
BRCA1 gene promoter methylation status in high-grade serous ovarian cancer patients--a study of the tumour Bank ovarian cancer (TOC) and ovarian cancer diagnosis consortium (OVCAD).
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
BRCA1 gene promoter methylatio ...... diagnosis consortium (OVCAD).
@ast
BRCA1 gene promoter methylatio ...... diagnosis consortium (OVCAD).
@en
type
label
BRCA1 gene promoter methylatio ...... diagnosis consortium (OVCAD).
@ast
BRCA1 gene promoter methylatio ...... diagnosis consortium (OVCAD).
@en
prefLabel
BRCA1 gene promoter methylatio ...... diagnosis consortium (OVCAD).
@ast
BRCA1 gene promoter methylatio ...... diagnosis consortium (OVCAD).
@en
P2093
P50
P1476
BRCA1 gene promoter methylatio ...... diagnosis consortium (OVCAD).
@en
P2093
D Cacsire-Tong
D Dimitrova
E I Braicu
I Vasconcelos
K Gellhaus
P Benedetti-Panici
S Darb-Esfahani
P304
P356
10.1016/J.EJCA.2014.05.001
P577
2014-06-02T00:00:00Z